Supply Chain

Agriculture

Read Wayne Winegarden’s Comments on Administration’s Trade Wars in Bankrate

The Trump administration’s trade wars are whipping Fed policy back and forth By Sarah Foster President Donald Trump’s trade wars just might prompt the Federal Reserve rate cut he’s been clamoring for — but for the wrong reasons. Weeks after the White House slapped higher duties on Chinese imports and threatened ...
Business & Economics

Wayne Winegarden Discusses Fears of US Recession in Yahoo! Finance Article

US recovery closes in on 10 year milestone as fears abound that the party is ending By Calder McHugh As the U.S. economy inches closer to a record-setting decade of sustained growth, experts are increasingly worried that a cliff — caused by a multi-front trade war —could be looming . ...
Agriculture

Let It Flow: Carlsbad Desalination Plant Expansion Approval A Bright Spot In A Dry State

With more than 800 miles of coastline and a great big ocean out there, California shouldn’t be always be scrambling for water as if it were in the middle of the Sahara Desert. But politics tend to make goods scarce rather than plentiful. But sometimes there’s good news. Such as ...
Commentary

Say No To Canadian Drug Imports

Lawmakers in the Sunshine State are looking to our northern neighbor to help them reduce drug prices. The Florida House of Representatives recently passed a bill that would allow the importation and sale of prescription drugs from Canada, where prices are generally lower because the government forcibly controls them. Florida isn’t the ...
Commentary

Middlemen Are Ripping Off State Medicaid Programs

Kentucky’s Democratic attorney general just launched an investigation to determine if middlemen in the prescription drug supply chain are ripping off the state’s Medicaid program. He’s almost certainly onto something. These middlemen, known as pharmacy benefit managers, or PBMs, administer drug benefit plans for Medicaid, Medicare Part D, and private insurers. In theory, ...
Commentary

Don’t blame drug companies for high prices

*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers hire third-party firms, ...
Commentary

Putting Drug Prices on TV Will Cause Unnecessary Patient Panic

Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Commentary

Why Health-Care Mergers Aren’t So Scary

Prominent politicos are voicing concerns about the wave of impending mergers in the health-care industry. On August 1, California insurance commissioner Dave Jones urged the Justice Department to block the merger of Aetna and CVS, fretting it “will have anticompetitive effects and … harm consumers.” Days later, the American Medical Association echoed his concerns. ...
Business & Economics

From Hooverville To Trumpville

In June of 1930 President Hoover signed the Smoot-Hawley Act. This Act imposed steep tariffs on over 20,000 different goods that Americans imported from other countries. As of its time, it was one of the largest tax increases in history. It was also one of the driving factors that turned ...
California

Congress Should Beware of ‘Unintended Consequences’ Of Tax Reform

If the U.S. economy is ever going to regain its past economic mojo, then Congress must pass comprehensive tax reform. Consider how much has changed since the last major tax reform in 1986. Back then, Bill Clinton was the governor of Arkansas, Mike Tyson had just become the youngest heavyweight ...
Agriculture

Read Wayne Winegarden’s Comments on Administration’s Trade Wars in Bankrate

The Trump administration’s trade wars are whipping Fed policy back and forth By Sarah Foster President Donald Trump’s trade wars just might prompt the Federal Reserve rate cut he’s been clamoring for — but for the wrong reasons. Weeks after the White House slapped higher duties on Chinese imports and threatened ...
Business & Economics

Wayne Winegarden Discusses Fears of US Recession in Yahoo! Finance Article

US recovery closes in on 10 year milestone as fears abound that the party is ending By Calder McHugh As the U.S. economy inches closer to a record-setting decade of sustained growth, experts are increasingly worried that a cliff — caused by a multi-front trade war —could be looming . ...
Agriculture

Let It Flow: Carlsbad Desalination Plant Expansion Approval A Bright Spot In A Dry State

With more than 800 miles of coastline and a great big ocean out there, California shouldn’t be always be scrambling for water as if it were in the middle of the Sahara Desert. But politics tend to make goods scarce rather than plentiful. But sometimes there’s good news. Such as ...
Commentary

Say No To Canadian Drug Imports

Lawmakers in the Sunshine State are looking to our northern neighbor to help them reduce drug prices. The Florida House of Representatives recently passed a bill that would allow the importation and sale of prescription drugs from Canada, where prices are generally lower because the government forcibly controls them. Florida isn’t the ...
Commentary

Middlemen Are Ripping Off State Medicaid Programs

Kentucky’s Democratic attorney general just launched an investigation to determine if middlemen in the prescription drug supply chain are ripping off the state’s Medicaid program. He’s almost certainly onto something. These middlemen, known as pharmacy benefit managers, or PBMs, administer drug benefit plans for Medicaid, Medicare Part D, and private insurers. In theory, ...
Commentary

Don’t blame drug companies for high prices

*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers hire third-party firms, ...
Commentary

Putting Drug Prices on TV Will Cause Unnecessary Patient Panic

Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Commentary

Why Health-Care Mergers Aren’t So Scary

Prominent politicos are voicing concerns about the wave of impending mergers in the health-care industry. On August 1, California insurance commissioner Dave Jones urged the Justice Department to block the merger of Aetna and CVS, fretting it “will have anticompetitive effects and … harm consumers.” Days later, the American Medical Association echoed his concerns. ...
Business & Economics

From Hooverville To Trumpville

In June of 1930 President Hoover signed the Smoot-Hawley Act. This Act imposed steep tariffs on over 20,000 different goods that Americans imported from other countries. As of its time, it was one of the largest tax increases in history. It was also one of the driving factors that turned ...
California

Congress Should Beware of ‘Unintended Consequences’ Of Tax Reform

If the U.S. economy is ever going to regain its past economic mojo, then Congress must pass comprehensive tax reform. Consider how much has changed since the last major tax reform in 1986. Back then, Bill Clinton was the governor of Arkansas, Mike Tyson had just become the youngest heavyweight ...
Scroll to Top